Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “breast cancer”

Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)Recruiting
NCT07295457NAUpdated Jul 31, 2026
Sponsor: Hospices Civils de Lyon
Breast Cancer
France
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense BreastsRecruiting
NCT05625659NAUpdated Jul 31, 2026
Sponsor: American College of Radiology
Breast Cancer
United States, Canada
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid TumorsRecruiting
NCT05372640Phase 1Updated Jul 31, 2026
Sponsor: National Cancer Institute (NCI)
Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma · Metastatic Malignant Solid Neoplasm
United States
Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast CancerActive Not Recruiting
NCT04052555Phase 1Updated Jul 31, 2026
Sponsor: National Cancer Institute (NCI)
Bilateral Breast Carcinoma · HER2-Negative Breast Carcinoma · Localized Breast Carcinoma · Recurrent Breast Carcinoma
United States
Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young WomenNot Yet Recruiting
NCT07735897N/AUpdated Jul 31, 2026
Sponsor: MedicalExcellence
Breast Cancer
South Korea
Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast CancerActive Not Recruiting
NCT04345913Phase 1, Phase 2Updated Jul 31, 2026
Sponsor: National Cancer Institute (NCI)
Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Triple-Negative Breast Carcinoma · Unresectable Triple-Negative Breast Carcinoma
United States
Effects of Negative Pressure Wound Bandaging After MastectomyRecruiting
NCT07607366NAUpdated Jul 31, 2026
Sponsor: Dalarna County Council, Sweden
Breast Cancer - Female
Sweden
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast CancerRecruiting
NCT04521764Phase 1Updated Jul 31, 2026
Sponsor: Mayo Clinic
Anatomic Stage IV Breast Cancer AJCC v8 · Invasive Breast Carcinoma · Metastatic Breast Adenocarcinoma · Recurrent Breast Carcinoma
United States
GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)Not Yet Recruiting
NCT07738341Phase 1, Phase 2Updated Jul 31, 2026
Sponsor: Eddingpharm (Zhuhai) Co., Ltd.
Breast Cancer (Locally Advanced or Metastatic)
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast CancerActive Not Recruiting
NCT02883062Phase 2Updated Jul 31, 2026
Sponsor: National Cancer Institute (NCI)
Invasive Breast Carcinoma · Stage II Breast Cancer AJCC v6 and v7 · Stage III Breast Cancer AJCC v7 · Triple-Negative Breast Carcinoma
United States
Adaptive Symptom Self-Management Immunotherapy StudyActive Not Recruiting
NCT05715255NAUpdated Jul 31, 2026
Sponsor: University of Arizona
Breast Cancer · Colon Cancer · Lung Cancer · Skin Cancer
United States
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerActive Not Recruiting
NCT02954874Phase 3Updated Jul 31, 2026
Sponsor: National Cancer Institute (NCI)
Breast Carcinoma In Situ · Invasive Breast Carcinoma · Stage I Breast Cancer AJCC v7 · Stage II Breast Cancer AJCC v6 and v7
United States, Canada, Puerto Rico
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment RecommendationsRecruiting
NCT07739121N/AUpdated Jul 31, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
Breast Neoplasms · Lung Neoplasms · Urologic Neoplasms · Prostatic Neoplasms
France
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic TestsRecruiting
NCT07106632Phase 3Updated Jul 31, 2026
Sponsor: UNICANCER
Early Breast Cancer · Premenopausal Breast Cancer · HR+/HER2- Breast Cancer
Belgium, France, Greece, Ireland, Italy +2 more
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized TrialRecruiting
NCT06954337NAUpdated Jul 31, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Breast Cancer · Prostate Cancer
United States
Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI WomenActive Not Recruiting
NCT06827704NAUpdated Jul 31, 2026
Sponsor: Rush University Medical Center
Metabolic Syndrome · Breast Cancer Prevention · Physical Activity
United States
Evaluation and Outcomes of SAVI Scout MD for Localized Breast SurgeryRecruiting
NCT07686250Phase 2Updated Jul 30, 2026
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Breast Cancer
United States
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)Active Not Recruiting
NCT04784715Phase 3Updated Jul 30, 2026
Sponsor: AstraZeneca
Breast Cancer; HER2-positive; Metastatic
United States, Argentina, Belgium, Brazil, Canada +22 more
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer SurvivorsActive Not Recruiting
NCT05896189NAUpdated Jul 30, 2026
Sponsor: NRG Oncology
Breast Cancer · Cognitive Impairments
United States, Puerto Rico
Intra-operative Detection of Positive Margins and Lymph Nodes in Breast SurgeryRecruiting
NCT06977698N/AUpdated Jul 30, 2026
Sponsor: University of Nottingham
Breast Cancer Invasive
United Kingdom
Comparison of Postoperative Analgesic Efficacy of Two Different Blocks in Modified Radical Mastectomy SurgeryNot Yet Recruiting
NCT07737132NAUpdated Jul 30, 2026
Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Breast Cancer · Postoperative Pain
24GUT540 : Meeting of Breast Cancer Patients and PathologistsCompleted
NCT07040514NAUpdated Jul 30, 2026
Sponsor: Dartmouth-Hitchcock Medical Center
Breast Cancer
United States
18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsActive Not Recruiting
NCT03168737Phase 1Updated Jul 30, 2026
Sponsor: M.D. Anderson Cancer Center
Malignant Breast Neoplasm · Malignant Colorectal Neoplasm · Malignant Pancreatic Neoplasm · Malignant Solid Neoplasm
United States
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal SubtypeRecruiting
NCT06486883Phase 2Updated Jul 30, 2026
Sponsor: MedSIR
Advanced Breast Cancer · Advanced Breast Carcinoma · Hormone Receptor Positive Breast Carcinoma
Austria, Belgium, France, Germany, Italy +5 more
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsRecruiting
NCT07288359Phase 1, Phase 2Updated Jul 30, 2026
Sponsor: Novartis Pharmaceuticals
Advanced HR+/HER2- Breast Cancer · Advanced CCNE1-amplified Solid Tumors · Metastatic Castration-resistant Prostate Cancer
United States, Czechia, Denmark, France, Germany +5 more

Previous page Next page